| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.096 | 0.1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |